Jesse Whitehead1, Nina Scott2, Polly Atatoa Carr3, Ross Lawrenson4. 1. Research Officer, National Institute of Demographic and Economic Analysis, University of Waikato, Hamilton. 2. Clinical Director Māori Health, Waikato District Health Board, Hamilton. 3. Associate Professor, National Institute of Demographic and Economic Analysis, University of Waikato, Hamilton. 4. Professor of Population Health, Waikato Medical Research Group, University of Waikato, Hamilton.
Abstract
AIM: This research examines the equity implications of the geographic distribution of COVID-19 vaccine delivery locations in Aotearoa New Zealand under five potential scenarios: (1) stadium mega-clinics; (2) Community Based Assessment Centres; (3) GP clinics; (4) community pharmacies; and (5) schools. METHOD: We mapped the distribution of Aotearoa New Zealand's population and the location of potential vaccine delivery facilities under each scenario. Geostatistical techniques identified population clusters for Māori, Pacific peoples and people aged 65 years and over. We calculated travel times between all potential facilities and each Statistical Area 1 in the country. Descriptive statistics indicate the size and proportion of populations that could face significant travel barriers when accessing COVID-19 vaccinations. RESULTS: Several areas with significant travel times to potential vaccine delivery sites were also communities identified as having an elevated risk of COVID-19 disease and severity. All potential scenarios for vaccine delivery, with the exception of schools, resulted in travel barriers for a substantial proportion of the population. Overall, these travel time barriers disproportionately burden Māori, older communities and people living in areas of high socioeconomic deprivation. CONCLUSION: The equitable delivery of COVID-19 vaccines is key to an elimination strategy. However, if current health services and facilities are used without well-designed and supported outreach services, then access to vaccination is likely to be inequitable.
AIM: This research examines the equity implications of the geographic distribution of COVID-19 vaccine delivery locations in Aotearoa New Zealand under five potential scenarios: (1) stadium mega-clinics; (2) Community Based Assessment Centres; (3) GP clinics; (4) community pharmacies; and (5) schools. METHOD: We mapped the distribution of Aotearoa New Zealand's population and the location of potential vaccine delivery facilities under each scenario. Geostatistical techniques identified population clusters for Māori, Pacific peoples and people aged 65 years and over. We calculated travel times between all potential facilities and each Statistical Area 1 in the country. Descriptive statistics indicate the size and proportion of populations that could face significant travel barriers when accessing COVID-19 vaccinations. RESULTS: Several areas with significant travel times to potential vaccine delivery sites were also communities identified as having an elevated risk of COVID-19 disease and severity. All potential scenarios for vaccine delivery, with the exception of schools, resulted in travel barriers for a substantial proportion of the population. Overall, these travel time barriers disproportionately burden Māori, older communities and people living in areas of high socioeconomic deprivation. CONCLUSION: The equitable delivery of COVID-19 vaccines is key to an elimination strategy. However, if current health services and facilities are used without well-designed and supported outreach services, then access to vaccination is likely to be inequitable.
Authors: Cheryl Davies; Carmen Timu-Parata; Jeannine Stairmand; Bridget Robson; Amanda Kvalsvig; Dominique Lum; Virginia Signal Journal: Int J Equity Health Date: 2022-05-17
Authors: Abolfazl Mollalo; Alireza Mohammadi; Sara Mavaddati; Behzad Kiani Journal: Int J Environ Res Public Health Date: 2021-11-16 Impact factor: 3.390
Authors: Kamil Faisal; Sultanah Alshammari; Reem Alotaibi; Areej Alhothali; Omaimah Bamasag; Nusaybah Alghanmi; Manal Bin Yamin Journal: Int J Environ Res Public Health Date: 2022-03-16 Impact factor: 3.390